[go: up one dir, main page]

Follow
Carmen Aguilar-Gurrieri
Carmen Aguilar-Gurrieri
Fundación Privada Instituto de Investigación de la Sida-Caixa
Verified email at irsicaixa.es
Title
Cited by
Cited by
Year
Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation
M Delvecchio, J Gaucher, C Aguilar-Gurrieri, E Ortega, D Panne
Nature structural & molecular biology 20 (9), 1040-1046, 2013
3272013
A systematic screen for protein–lipid interactions in Saccharomyces cerevisiae
O Gallego, MJ Betts, J Gvozdenovic‐Jeremic, K Maeda, C Matetzki, ...
Molecular systems biology 6 (1), 430, 2010
1972010
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity
B Trinite, F Tarres-Freixas, J Rodon, E Pradenas, V Urrea, S Marfil, ...
Scientific Reports 11 (1), 2608, 2021
1212021
Structural evidence for Nap1‐dependent H2A–H2B deposition and nucleosome assembly
C Aguilar‐Gurrieri, A Larabi, V Vinayachandran, NA Patel, K Yen, R Reja, ...
The EMBO journal 35 (13), 1465-1482, 2016
1022016
Production of HIV-1-based virus-like particles for vaccination: achievements and limits
L Cervera, F Gòdia, F Tarrés-Freixas, C Aguilar-Gurrieri, J Carrillo, ...
Applied microbiology and biotechnology 103 (18), 7367-7384, 2019
812019
CHMP1B is a target of USP8/UBPY regulated by ubiquitin during endocytosis
X Crespo-Yàñez, C Aguilar-Gurrieri, AC Jacomin, A Journet, M Mortier, ...
PLoS genetics 14 (6), e1007456, 2018
562018
New emerging targets in cancer immunotherapy: the role of neoantigens
L De Mattos-Arruda, J Blanco-Heredia, C Aguilar-Gurrieri, J Carrillo, ...
ESMO open 4, e000684, 2019
412019
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses
F Tarrés-Freixas, C Aguilar-Gurrieri, ML Rodríguez de la Concepción, ...
npj Vaccines 8 (1), 51, 2023
252023
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines
C Aguilar-Gurrieri, A Barajas, C Rovirosa, R Ortiz, V Urrea, N de la Iglesia, ...
Cancer Immunology, Immunotherapy 72 (7), 2113-2125, 2023
182023
HIV-1 trans-Infection Mediated by DCs: The Tip of the Iceberg of Cell-to-Cell Viral Transmission
D Perez-Zsolt, D Raïch-Regué, J Muñoz-Basagoiti, C Aguilar-Gurrieri, ...
Pathogens 11 (1), 39, 2021
152021
VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice
B Trinité, E Durr, A Pons-Grífols, G O'Donnell, C Aguilar-Gurrieri, ...
Vaccine 42 (15), 3474-3485, 2024
122024
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization
E Pradenas, S Marfil, V Urrea, T Pidkova, A Pons-Grífols, R Ortiz, ...
Iscience 26 (4), 2023
112023
Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice
A Barajas, P Amengual-Rigo, A Pons-Grífols, R Ortiz, O Gracia Carmona, ...
Journal of translational medicine 22 (1), 14, 2024
82024
Exploring FeLV-gag-based VLPs as a new vaccine platform—analysis of production and immunogenicity
R Ortiz, A Barajas, A Pons-Grífols, B Trinité, F Tarrés-Freixas, C Rovirosa, ...
International journal of molecular sciences 24 (10), 9025, 2023
72023
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses. NPJ Vaccines [Internet]. 2023; 8: 51
F Tarrés-Freixas, C Aguilar-Gurrieri, ML Rodríguez de la Concepción, ...
Cited Here, 0
5
Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters
E Pradenas, V Urrea, S Marfil, T Pidkova, C Aguilar-Gurrieri, F Abancó, ...
Journal of Translational Medicine 23 (1), 783, 2025
32025
Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein
R Ortiz, A Barajas, A Pons-Grífols, B Trinité, F Tarrés-Freixas, C Rovirosa, ...
Viruses 16 (6), 987, 2024
22024
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant
C Ávila-Nieto, J Vergara-Alert, P Amengual-Rigo, E Ainsua-Enrich, ...
Frontiers in immunology 14, 1291972, 2023
22023
Full wwPDB X-ray Structure Validation Report i
H Wang, E Gouaux
Word wide protein data bank, 2009
22009
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection
C Ávila-Nieto, J Vergara-Alert, P Amengual-Rigo, E Ainsua-Enrich, ...
Nature Communications 15 (1), 2349, 2024
12024
The system can't perform the operation now. Try again later.
Articles 1–20